Cargando…
A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, and tumor recurrence and metastasis are major factors that contribute to the poor outcome of patients with HCC. Long noncoding RNAs (lncRNAs) are known to regulate different tumorigenic processes, and a grow...
Autores principales: | Ni, Wen, Zhang, Yuqin, Zhan, Zetao, Ye, Feng, Liang, Yonghao, Huang, Jing, Chen, Keli, Chen, Longhua, Ding, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395742/ https://www.ncbi.nlm.nih.gov/pubmed/28420424 http://dx.doi.org/10.1186/s13045-017-0449-4 |
Ejemplares similares
-
Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
por: Ni, Wen, et al.
Publicado: (2023) -
Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma
por: Zhang, Yuqin, et al.
Publicado: (2018) -
Involvement of transcribed lncRNA uc.291 in hyperproliferative skin disorders
por: Mancini, Mara, et al.
Publicado: (2023) -
Analysis of Long Non-Coding RNA (lncRNA) uc.38 and uc.63 Expression in Breast Carcinoma Patients
por: Zadrożna-Nowak, Anna, et al.
Publicado: (2022) -
m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression
por: Zhang, Heng, et al.
Publicado: (2022)